Sachin Gopalkrishna Pai

Author

Also Known As

Leung, Kathy H. T., S. Pai, Sachin A. Pai, Sachin G Pai, Sachin G. Pai, Sachin Gopalkrishna Pai, Sachin Pai, SachinGopalakrishna Pai, Seong I. Pai, Siddharth Pai

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

USA Mitchell Cancer Institute University of South Alabama Northwestern University Wake Forest University Sylvester Comprehensive Cancer Center

About

Sachin Gopalkrishna Pai is an author at USA Mitchell Cancer Institute specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	279
2	Cell Biology	2	2	27
3	Health Sciences	1	1	112
4	Emergency Medicine	1	1	10
5	Gastroenterology	1	1	18

Sachin Gopalkrishna Pai

Publications

466

Citations

H-Index

Page 1

	Year	Citations
Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA Young Kwang Chae, Andrew A. Davis, Benedito A. Carneiro, Oncotarget Dna AnalysisPathologyTumor BiologyOncologyTumor Heterogeneity	2016	112
Genomic characterization of high-risk non-muscle invasive bladder cancer Joshua J. Meeks, Benedito A. Carneiro, Sachin Gopalkrishna Pai, Oncotarget UrologyOncologyGenitourinary CancerTumor HeterogeneityMedicine	2016	71
Correlation of tumor mutational burden and treatment outcomes in patients with colorectal cancer Sachin Gopalkrishna Pai, Benedito A. Carneiro, Young Kwang Chae, Journal of Gastrointestinal Oncology	2017	46
Angiotensin receptor blockers Gowtham Rao, Joshua R. Mann, Azza Shoaibi, Journal of Hypertension	2013	41
Phase I study of the arginase inhibitor INCB001158 (1158) alone and in combination with pembrolizumab (PEM) in patients (Pts) with advanced/metastatic (adv/met) solid tumours Aung Naing, Todd M. Bauer, K. Papadopoulos, Annals of Oncology OncologyGenitourinary CancerMedicineArginase Inhibitor Incb001158Solid Tumours	2019	41
Exosomal markers (CD63 and CD9) expression and their prognostic significance using immunohistochemistry in patients with pancreatic ductal adenocarcinoma Moh’d Khushman, Girijesh Kumar Patel, Javier A. Laurini, Journal of Gastrointestinal Oncology	2019	30
The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer Misako Nagasaka, Vijendra K. Singh, Yasmine Baca, Clinical Lung Cancer	2021	26
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial Alexander Olawaiye, Laurence Gladieff, David M. O’Malley, The Lancet	2025	24
Thymineless Death by the Fluoropyrimidine Polymer F10 Involves Replication Fork Collapse and Is Enhanced by Chk1 Inhibition Chinnadurai Mani, Sachin Gopalkrishna Pai, Cinta M. Papke, Neoplasia	2018	20
The Prevalence of DPYD*9A (c.85T>C) Genotype and the Genotype-Phenotype Correlation in Patients with Gastrointestinal Malignancies Treated With Fluoropyrimidines: Updated Analysis Anu S. Maharjan, Gwendolyn A. McMillin, Girijesh Kumar Patel, Clinical Colorectal Cancer Gastrointestinal Malignancies TreatedCancer RiskGastrointestinal OncologyMedicineGenetic Epidemiology	2019	18

Page 1